It was intended to serve as a pivotal moment for obesity treatment in the UK. However, the introduction of the new weight loss medication tirzepatide, branded as Mounjaro, is revealing significant flaws within the healthcare system. Researchers from King’s College London caution that the National Health Service’s stringent eligibility criteria could lead to a two-tiered […]
Read More